APA (7th ed.) Citation

X, Y., H, L., J, L., Y, S., R, Z., Y, C., . . . Z, R. (2026). Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity. Signal transduction and targeted therapy, 11(1), . https://doi.org/10.1038/s41392-026-02667-8

Chicago Style (17th ed.) Citation

X, Yu, et al. "Targeting Tumor-specific T Cells with LAG3-directed Interleukin-2 Prevents T-cell Exhaustion and Reinvigorates Antitumor Immunity." Signal Transduction and Targeted Therapy 11, no. 1 (2026). https://doi.org/10.1038/s41392-026-02667-8.

MLA (9th ed.) Citation

X, Yu, et al. "Targeting Tumor-specific T Cells with LAG3-directed Interleukin-2 Prevents T-cell Exhaustion and Reinvigorates Antitumor Immunity." Signal Transduction and Targeted Therapy, vol. 11, no. 1, 2026, https://doi.org/10.1038/s41392-026-02667-8.